Rivaroxaban: particular conditions of prescription in Murcia and Alicante, Spain

Re: Martinez CC, Cerezo Manchado JJ, Flores Blanco PJ, et al. Effectiveness and safety of rivaroxaban in nonvalvular atrial fibrillation: data from a contemporary Spanish registry. Curr Med Res Opin. 2019. https://doi.org/10.1080/03007995.2019.1600483

Gabriel Cismaru5th Department of Internal Medicine, Cardiology Rehabilitation, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, RomaniaCorrespondence[email protected]

http://orcid.org/0000-0002-7352-9584

References

Martinez CC, Cerezo Manchado JJ, Flores Blanco PJ, et al. Effectiveness and safety of rivaroxaban in nonvalvular atrial fibrillation: data from a contemporary Spanish registry. Curr Med Res Opin. 2019. DOI:10.1080/03007995.2019.1600483
Web of Science ®Google Scholar
Martinez CAA, Lanas F, Radaideh G, et al. Xantus-EL a real-world prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America. Egypt Heart J. 2018;70:307–313.
PubMedGoogle Scholar
Camm AJ, Amarenco P, Haas S, et al. XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation. Eur Heart J. 2016;37:1145–1153.
PubMed Web of Science ®Google Scholar
Kim YH, Thanachartwet T, Camm J, et al. XANAP: real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation. J Arrhythmia. 2016;32:j131. Abstract P2-116
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Rivaroxaban: particular conditions of prescription in Murcia and Alicante, Spain

Re: Martinez CC, Cerezo Manchado JJ, Flores Blanco PJ, et al. Effectiveness and safety of rivaroxaban in nonvalvular atrial fibrillation: data from a contemporary Spanish registry. Curr Med Res Opin. 2019. https://doi.org/10.1080/03007995.2019.1600483

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Rivaroxaban: particular conditions of prescription in Murcia and Alicante, Spain

Re: Martinez CC, Cerezo Manchado JJ, Flores Blanco PJ, et al. Effectiveness and safety of rivaroxaban in nonvalvular atrial fibrillation: data from a contemporary Spanish registry. Curr Med Res Opin. 2019. https://doi.org/10.1080/03007995.2019.1600483

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date